Alternative Roles for CRISPR/Cas Systems in Bacterial Pathogenesis
article has not abstract
Vyšlo v časopise:
Alternative Roles for CRISPR/Cas Systems in Bacterial Pathogenesis. PLoS Pathog 9(10): e32767. doi:10.1371/journal.ppat.1003621
Kategorie:
Pearls
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1003621
Souhrn
article has not abstract
Zdroje
1. MakarovaKS, HaftDH, BarrangouR, BrounsSJ, CharpentierE, et al. (2011) Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9: 467–477.
2. DeltchevaE, ChylinskiK, SharmaCM, GonzalesK, ChaoY, et al. (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471: 602–607.
3. YosefI, GorenMG, QimronU (2012) Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res 40: 5569–5576.
4. DatsenkoKA, PougachK, TikhonovA, WannerBL, SeverinovK, et al. (2012) Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat Commun 3: 945.
5. SampsonTR, SarojSD, LlewellynAC, TzengYL, WeissDS (2013) A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 497: 254–257.
6. JinekM, ChylinskiK, FonfaraI, HauerM, DoudnaJA, et al. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816–821.
7. GasiunasG, BarrangouR, HorvathP, SiksnysV (2012) Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A 109: E2579–2586.
8. LouwenR, Horst-KreftD, de BoerAG, van der GraafL, de KnegtG, et al. (2013) A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome. Eur J Clin Microbiol Infect Dis 32: 207–226.
9. GundersonFF, CianciottoNP (2013) The CRISPR-associated gene cas2 of Legionella pneumophila is required for intracellular infection of amoebae. MBio 4: e00074–00013.
10. Abu KwaikY, GaoLY, StoneBJ, VenkataramanC, HarbOS (1998) Invasion of protozoa by Legionella pneumophila and its role in bacterial ecology and pathogenesis. Appl Environ Microbiol 64: 3127–3133.
11. CadyKC, O'TooleGA (2011) Non-identity-mediated CRISPR-bacteriophage interaction mediated via the Csy and Cas3 proteins. J Bacteriol 193: 3433–3445.
12. ZegansME, WagnerJC, CadyKC, MurphyDM, HammondJH, et al. (2009) Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa. J Bacteriol 191: 210–219.
13. BabuM, BeloglazovaN, FlickR, GrahamC, SkarinaT, et al. (2011) A dual function of the CRISPR-Cas system in bacterial antivirus immunity and DNA repair. Mol Microbiol 79: 484–502.
14. SuvarnapunyaAE, LagasseHA, SteinMA (2003) The role of DNA base excision repair in the pathogenesis of Salmonella enterica serovar Typhimurium. Mol Microbiol 48: 549–559.
15. SternA, KerenL, WurtzelO, AmitaiG, SorekR (2010) Self-targeting by CRISPR: gene regulation or autoimmunity? Trends Genet 26: 335–340.
16. JorthP, WhiteleyM (2012) An evolutionary link between natural transformation and CRISPR adaptive immunity. MBio 3: e00309–12.
17. VercoeRB, ChangJT, DyRL, TaylorC, GristwoodT, et al. (2013) Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet 9: e1003454 doi:10.1371/journal.pgen.1003454
18. WestraER, BrounsSJ (2012) The rise and fall of CRISPRs–dynamics of spacer acquisition and loss. Mol Microbiol 85: 1021–1025.
19. QiLS, LarsonMH, GilbertLA, DoudnaJA, WeissmanJS, et al. (2013) Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152: 1173–1183.
20. CadyKC, Bondy-DenomyJ, HeusslerGE, DavidsonAR, O'TooleGA (2012) The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J Bacteriol 194: 5728–5738.
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2013 Číslo 10
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Dengue Vaccines: Strongly Sought but Not a Reality Just Yet
- MicroRNA-155 Promotes Autophagy to Eliminate Intracellular Mycobacteria by Targeting Rheb
- Alternative Roles for CRISPR/Cas Systems in Bacterial Pathogenesis
- RNA Biology in Fungal Phytopathogens